105 related articles for article (PubMed ID: 8232827)
1. New developments in the use of anticonvulsants as mood stabilizers.
Post RM; Ketter TA; Pazzaglia PJ; George MS; Marangell L; Denicoff K
Neuropsychobiology; 1993; 27(3):132-7. PubMed ID: 8232827
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and use of anticonvulsants in mood disorders.
Dunn RT; Frye MS; Kimbrell TA; Denicoff KD; Leverich GS; Post RM
Clin Neuropharmacol; 1998; 21(4):215-35. PubMed ID: 9704164
[TBL] [Abstract][Full Text] [Related]
3. New concepts in mood stabilization: evidence for the effectiveness of valproate and lamotrigine.
Bowden CL
Neuropsychopharmacology; 1998 Sep; 19(3):194-9. PubMed ID: 9653707
[TBL] [Abstract][Full Text] [Related]
4. A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures.
Post RM; Weiss SR
Mol Neurobiol; 1996 Aug; 13(1):33-60. PubMed ID: 8892335
[TBL] [Abstract][Full Text] [Related]
5. The action of mood-stabilizers in affective disorders: an integrative view as a challenge.
Emrich HM; Dose M; Wolf R
Neuropsychobiology; 1993; 27(3):158-62. PubMed ID: 8232832
[TBL] [Abstract][Full Text] [Related]
6. Rational polypharmacy in the bipolar affective disorders.
Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
[TBL] [Abstract][Full Text] [Related]
7. Anticonvulsants in affective disorders.
Small JG
Psychopharmacol Bull; 1990; 26(1):25-36. PubMed ID: 2196624
[TBL] [Abstract][Full Text] [Related]
8. Introduction: the use of mood stabilizers in the treatment of psychiatric disorders.
Bowden CL
J Clin Psychiatry; 1999; 60 Suppl 5():3-4. PubMed ID: 10192401
[No Abstract] [Full Text] [Related]
9. [Mood regulator agents (excluding lithium)].
Rouillon F
Rev Prat; 1994 Nov; 44(17):2307-10. PubMed ID: 7984937
[TBL] [Abstract][Full Text] [Related]
10. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
[TBL] [Abstract][Full Text] [Related]
11. The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders.
Gray NA; Zhou R; Du J; Moore GJ; Manji HK
J Clin Psychiatry; 2003; 64 Suppl 5():3-17. PubMed ID: 12720479
[TBL] [Abstract][Full Text] [Related]
12. Treatment-resistant bipolar disorder.
Gitlin M
Mol Psychiatry; 2006 Mar; 11(3):227-40. PubMed ID: 16432528
[TBL] [Abstract][Full Text] [Related]
13. [Antiepileptic drugs as mood stabilizers: what did we learn from the epileptology?].
Rajna P
Ideggyogy Sz; 2008 Sep; 61(9-10):305-16. PubMed ID: 18841650
[TBL] [Abstract][Full Text] [Related]
14. Mood stabilizers in children and adolescents.
Ryan ND; Bhatara VS; Perel JM
J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):529-36. PubMed ID: 10230184
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of atypical antipsychotics in mood disorders.
Yatham LN
J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S9-14. PubMed ID: 12832944
[TBL] [Abstract][Full Text] [Related]
16. Mood stabilizers: protecting the mood...protecting the brain.
Brunello N
J Affect Disord; 2004 Apr; 79 Suppl 1():S15-20. PubMed ID: 15121343
[TBL] [Abstract][Full Text] [Related]
17. PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers.
Manji HK; Chen G
Mol Psychiatry; 2002; 7 Suppl 1():S46-56. PubMed ID: 11986995
[TBL] [Abstract][Full Text] [Related]
18. Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder.
Ketter TA; Nasrallah HA; Fagiolini A
Psychopharmacol Bull; 2006; 39(1):120-46. PubMed ID: 17065977
[TBL] [Abstract][Full Text] [Related]
19. Choosing lithium, anticonvulsant, or electroconvulsant therapy for mood disorders.
Gross R; Grunhaus L
South Med J; 1995 Feb; 88(2):249-50. PubMed ID: 7839179
[No Abstract] [Full Text] [Related]
20. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
Yatham LN; Kennedy SH; O'Donovan C; Parikh S; MacQueen G; McIntyre R; Sharma V; Silverstone P; Alda M; Baruch P; Beaulieu S; Daigneault A; Milev R; Young LT; Ravindran A; Schaffer A; Connolly M; Gorman CP;
Bipolar Disord; 2005; 7 Suppl 3():5-69. PubMed ID: 15952957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
